Influence of mercury chloride-renal failure on pharmacokinetics of sulphamethoxazole after oral administration in mice
Loading...
Date
2010
Journal Title
Journal ISSN
Volume Title
Publisher
Selçuk Üniversitesi Veterinerlik Fakültesi
Access Rights
info:eu-repo/semantics/openAccess
Abstract
Amaç: Bu çalışmada, deneysel olarak cıva klorür ile böbrek hasarı oluşturulmuş farelerde 100 mg/kg dozda oral yolla uygulanan sülfametoksazolün farmakokinetiği değerlendirildi. Gereç ve Yöntem: Cıva klorür farelere 3 ve 6 mg/kg dozlarında verildi. Plazma sülfametaksazol konsantrasyonları spektrofotometre ile ölçüldü. Plazma konsantrasyon-zaman verileri dikkate alındığında ilacın 2 kompartmanlı açık modele uygun olduğu görüldü. Bulgular: Böbrek hasarı ile ilişkili olarak sülfametoksazolün emilim (AUC and t1/2a) ve eliminasyon (t1/2? and MRT) fazlarında önemli bulgular (p<0.05) gözlendi. Hasara bağlı olarak eğrinin altında kalan alan değeri düşerken, ortalama kalış zamanında artış tespit edildi (p<0.05). Öneri: Böbrek hasarlı hastalarda, sülfametoksazolün doz ve uygulama aralıklarının hasarın derecesine göre belirlenmesi çok önemlidir
Aim: The effects of renal failure on the pharmacokinetics of sulphamethoxazole were investigated after oral administration of 100 mg/kg of the drug using a mice model of mercury chloride-induced renal failure. Materials and Methods: Mercury chloride was given to mice at the doses of 3 and 6 mg/kg. Plasma sulphamethoxazole concentrations were measured by spectrophotometer. Plasma concentration-time data were fitted to a two-compartment open model. Results: Significant findings (p<0.05) were observed for absorption (AUC and t1/2a) and elimination (t1/2? and MRT) phases of sulphamethoxazole related with renal failure. Also area under the curve value decreased, and mean residence time value increased with renal failure (p<0.05). Conclusion: Study result showed that dosage and administration intervals of sulphamethoxazole were important for patients with renal failure.
Aim: The effects of renal failure on the pharmacokinetics of sulphamethoxazole were investigated after oral administration of 100 mg/kg of the drug using a mice model of mercury chloride-induced renal failure. Materials and Methods: Mercury chloride was given to mice at the doses of 3 and 6 mg/kg. Plasma sulphamethoxazole concentrations were measured by spectrophotometer. Plasma concentration-time data were fitted to a two-compartment open model. Results: Significant findings (p<0.05) were observed for absorption (AUC and t1/2a) and elimination (t1/2? and MRT) phases of sulphamethoxazole related with renal failure. Also area under the curve value decreased, and mean residence time value increased with renal failure (p<0.05). Conclusion: Study result showed that dosage and administration intervals of sulphamethoxazole were important for patients with renal failure.
Description
Keywords
Sülfametoksazol, farmakokinetik, böbrek yetmezliği, cıva klorür, Sulphamethoxazole, pharmacokinetic, renal failure, mercury chloride
Journal or Series
Eurasian Journal of Veterinary Sciences
WoS Q Value
Scopus Q Value
Volume
26
Issue
1
Citation
Yarsan, E., Altıntas, A., Essiz, D., Altintas, L., Pekcan, M., Ciftci, G., Ibrahim, I. G., (2010). Influence of mercury chloride-renal failure on pharmacokinetics of sulphamethoxazole after oral administration in mice. Eurasian Journal of Veterinary Sciences, 26 (1), 21-24.
